D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global Cancer Statistics, 2002, Global cancer statistics, pp.74-108, 2002.
DOI : 10.3322/canjclin.55.2.74

J. Sciotto, C. Oobrien, and M. , Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus, Laryngoscope, vol.117, pp.2115-2143, 2007.

A. Chaturvedi, E. Engels, and R. Pfeiffer, Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States, Journal of Clinical Oncology, vol.29, issue.32, pp.4294-301, 2011.
DOI : 10.1200/JCO.2011.36.4596

G. Ddsouza, A. Kreimer, and R. Viscidi, Case???Control Study of Human Papillomavirus and Oropharyngeal Cancer, New England Journal of Medicine, vol.356, issue.19, pp.1944-56, 2007.
DOI : 10.1056/NEJMoa065497

K. Ang, J. Harris, and R. Wheeler, Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, New England Journal of Medicine, vol.363, issue.1, pp.24-35, 2010.
DOI : 10.1056/NEJMoa0912217

C. Salazar, N. Anayannis, and R. Smith, Combined P16 and human papillomavirus testing predicts head and neck cancer survival, International Journal of Cancer, vol.42, issue.Suppl 10, 2014.
DOI : 10.1002/ijc.28876

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159440

S. Haddad and A. Khairallah, A FORGOTTEN CHAPTER IN THE HISTORY OF THE CIRCULATION OF THE BLOOD, Annals of Surgery, vol.104, issue.1, pp.1-8, 1936.
DOI : 10.1097/00000658-193607000-00001

M. Malpighi, De pulmonibus observationes anatomicae. 1661. 11 His WS. Die Häute une Höhlen des Körpers, p.1865

W. Waldeyer, . Kittsubsantz, and . Grunsubstanz, Kittsubstanz und Grundsubstanz, Epithel und Endothel, Archiv f??r Mikroskopische Anatomie, vol.XVI, issue.2, pp.1-8, 1901.
DOI : 10.1007/BF02975315

G. Philipson, The Bradshawe Lecture on the Pathological Relations of the Absorbent System, BMJ, vol.2, issue.1234, pp.353-360, 1884.
DOI : 10.1136/bmj.2.1234.353

E. Landis, The relation between capillary pressure and the rate at which fluid passes through the walls of single capillaries, Am J Physiol, vol.82, pp.217-255, 1927.

G. Palade, AN ELECTRON MICROSCOPE STUDY OF THE MITOCHONDRIAL STRUCTURE, Journal of Histochemistry & Cytochemistry, vol.1, issue.4, pp.188-211, 1953.
DOI : 10.1177/1.4.188

W. Aird, Endothélium in history, In: Endothelial Biomedicine, 2007.

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-938, 2005.
DOI : 10.1038/nature04478

H. Dvorak, J. Nagy, D. Feng, L. Brown, and A. Dvorak, Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis, Curr Top Microbiol Immunol, vol.237, pp.97-132, 1999.
DOI : 10.1007/978-3-642-59953-8_6

C. Suri, P. Jones, and S. Patan, Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis, Cell, vol.87, issue.7, pp.1171-80, 1996.
DOI : 10.1016/S0092-8674(00)81813-9

H. Wang, Z. Chen, and D. Anderson, Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4, Cell, vol.93, issue.5, pp.741-53, 1998.
DOI : 10.1016/S0092-8674(00)81436-1

G. Yancopoulos, S. Davis, N. Gale, J. Rudge, S. Wiegand et al., Vascular-specific growth factors and blood vessel formation, Nature, vol.407, issue.6801, pp.242-250, 2000.
DOI : 10.1038/35025215

G. Thurston, C. Suri, and K. Smith, Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1, Science, vol.286, issue.5449, pp.2511-2515, 1999.
DOI : 10.1126/science.286.5449.2511

S. Weis and D. Cheresh, Tumor angiogenesis: molecular pathways and therapeutic targets, Nature Medicine, vol.10, issue.11, pp.1359-70, 2011.
DOI : 10.1038/nm.1971

V. Baeriswyl and G. Christofori, The angiogenic switch in carcinogenesis, Seminars in Cancer Biology, vol.19, issue.5, pp.329-366, 2009.
DOI : 10.1016/j.semcancer.2009.05.003

D. Hanahan and J. Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis, Cell, vol.86, issue.3, pp.353-64, 1996.
DOI : 10.1016/S0092-8674(00)80108-7

J. Holash, S. Wiegand, and G. Yancopoulos, New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF, Oncogene, vol.18, issue.38, pp.5356-62, 1999.
DOI : 10.1038/sj.onc.1203035

C. M?rg?ritescu, C. Simionescu, D. Pirici, L. Mogoant?, R. Ciurea et al., Immunohistochemical characterization of tumoral vessels in oral squamous cell carcinoma, Rom J Morphol Embryol, vol.49, pp.447-58, 2008.

C. M?rg?ritescu, C. Simionescu, and L. Mogoant?, Endoglin (CD105) and microvessel density in oral squamous cell carcinoma, Rom J Morphol Embryol, vol.49, pp.321-327, 2008.

M. Gee, W. Procopio, S. Makonnen, M. Feldman, N. Yeilding et al., Tumor Vessel Development and Maturation Impose Limits on the Effectiveness of Anti-Vascular Therapy, The American Journal of Pathology, vol.162, issue.1, pp.183-93, 2003.
DOI : 10.1016/S0002-9440(10)63809-6

W. Kamoun, C. S. Lacorre, and D. , Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks, Nature Methods, vol.26, issue.8, pp.655-60, 2010.
DOI : 10.1038/nmeth.1475

R. Tong, Y. Boucher, S. Kozin, F. Winkler, D. Hicklin et al., Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors, Cancer Research, vol.64, issue.11, pp.3731-3737, 2004.
DOI : 10.1158/0008-5472.CAN-04-0074

T. Padera, B. Stoll, J. Tooredman, D. Capen, E. Di-tomaso et al., Pathology: Cancer cells compress intratumour vessels, Nature, vol.427, issue.6976, p.695, 2004.
DOI : 10.1038/427695a

K. Declerck and R. Elble, The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy, Frontiers in Bioscience, vol.15, issue.1, pp.213-238, 2010.
DOI : 10.2741/3616

N. Weidner, J. Folkman, and F. Pozza, Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma, JNCI Journal of the National Cancer Institute, vol.84, issue.24, pp.1875-87, 1992.
DOI : 10.1093/jnci/84.24.1875

B. Nico, V. Benagiano, D. Mangieri, N. Maruotti, A. Vacca et al., Evaluation of microvascular density in tumors: pro and contra, Histol Histopathol, vol.23, pp.601-608, 2008.

M. Yu, L. Liu, and C. Liang, Intratumoral vessel density as prognostic factors in head and neck squamous cell carcinoma: A meta-analysis of literature, Head & Neck, vol.359, issue.4, pp.596-602, 2014.
DOI : 10.1002/hed.23301

P. Tofts, G. Brix, and D. Buckley, Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols, Journal of Magnetic Resonance Imaging, vol.10, issue.3, pp.223-255, 1999.
DOI : 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S

S. Sandrone, M. Bacigaluppi, and M. Galloni, Weighing brain activity with the balance: Angelo Mosso???s original manuscripts come to light, Brain, vol.137, issue.2, pp.621-654, 2014.
DOI : 10.1093/brain/awt091

C. Roy and C. Sherrington, On the Regulation of the Blood-supply of the Brain, The Journal of Physiology, vol.11, issue.1-2, pp.85-158, 1890.
DOI : 10.1113/jphysiol.1890.sp000321

C. White, W. Pope, and T. Zaw, Regional and Voxel-Wise Comparisons of Blood Flow Measurements Between Dynamic Susceptibility Contrast Magnetic Resonance Imaging (DSC-MRI) and Arterial Spin Labeling (ASL) in Brain Tumors, Journal of Neuroimaging, vol.44, issue.3, pp.23-30, 2014.
DOI : 10.1111/j.1552-6569.2012.00703.x

M. Mulder, L. Van-maanen, and B. Forstmann, Perceptual decision neurosciences ??? A model-based review, Neuroscience, vol.277, pp.872-84, 2014.
DOI : 10.1016/j.neuroscience.2014.07.031

F. Calamante, Perfusion MRI Using Dynamic-Susceptibility Contrast MRI, Topics in Magnetic Resonance Imaging, vol.21, issue.2, pp.75-85, 2010.
DOI : 10.1097/RMR.0b013e31821e53f5

S. Sourbron, M. Heilmann, and A. Biffar, -measurement, Magnetic Resonance in Medicine, vol.7, issue.3, pp.672-81, 2009.
DOI : 10.1002/mrm.22042

S. Chinchure, B. Thomas, and S. Wangju, Mean intensity curve on dynamic contrast-enhanced susceptibility-weighted perfusion MR imaging ??? review of a new parameter to differentiate intracranial tumors, Journal of Neuroradiology, vol.38, issue.4, pp.199-206, 2011.
DOI : 10.1016/j.neurad.2011.07.002

M. Vliet, C. Van-dijke, and P. Wielopolski, MR Angiography of Tumor-related Vasculature: From the Clinic to the Micro-environment, RadioGraphics, vol.25, issue.suppl_1, pp.85-97, 2005.
DOI : 10.1148/rg.25si055512

G. Jahng, K. Li, L. Ostergaard, and F. Calamante, Perfusion Magnetic Resonance Imaging: A Comprehensive Update on Principles and Techniques, Korean Journal of Radiology, vol.15, issue.5, pp.554-77, 2014.
DOI : 10.3348/kjr.2014.15.5.554

C. Cuenod and D. Balvay, Perfusion and vascular permeability: Basic concepts and measurement in DCE-CT and DCE-MRI, Diagnostic and Interventional Imaging, vol.94, issue.12, pp.1187-204, 2013.
DOI : 10.1016/j.diii.2013.10.010

A. Padhani, C. Hayes, S. Landau, and M. Leach, Reproducibility of quantitative dynamic MRI of normal human tissues, NMR in Biomedicine, vol.60, issue.2, pp.143-53, 2002.
DOI : 10.1002/nbm.732

S. Espinoza and P. Halimi, Interpretation pearls for MR imaging of parotid gland tumor, European Annals of Otorhinolaryngology, Head and Neck Diseases, vol.130, issue.1, pp.30-35, 2013.
DOI : 10.1016/j.anorl.2011.12.006

C. Roberts, B. Issa, A. Stone, A. Jackson, J. Waterton et al., Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies, Journal of Magnetic Resonance Imaging, vol.23, issue.4, pp.554-63, 2006.
DOI : 10.1002/jmri.20529

I. Thomassin-naggara, E. Daraï, C. Cuenod, R. Rouzier, P. Callard et al., Dynamic contrast-enhanced magnetic resonance imaging: A useful tool for characterizing ovarian epithelial tumors, Journal of Magnetic Resonance Imaging, vol.10, issue.1, pp.111-131, 2008.
DOI : 10.1002/jmri.21377

S. Kety and C. Schmidt, THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES 1, Journal of Clinical Investigation, vol.27, issue.4, pp.476-83, 1948.
DOI : 10.1172/JCI101994

E. Renkin, Effects of blood flow on diffusion kinetics in isolated, perfused hindlegs of cats; a double circulation hypothesis, Am J Physiol, vol.183, pp.125-161, 1955.

P. Tofts and A. Kermode, Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI., Journal of Neurology, Neurosurgery & Psychiatry, vol.52, issue.8, pp.1019-1039, 1989.
DOI : 10.1136/jnnp.52.8.1019

P. Tofts and A. Kermode, Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts, Magnetic Resonance in Medicine, vol.113, issue.2, pp.357-67, 1991.
DOI : 10.1002/mrm.1910170208

M. Leach, K. Brindle, and J. Evelhoch, The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations, British Journal of Cancer, vol.16, issue.9, pp.1599-610, 2005.
DOI : 10.1002/1522-2586(200006)11:6<575::AID-JMRI2>3.0.CO;2-1

L. Axel, Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis., Radiology, vol.137, issue.3, pp.679-86, 1980.
DOI : 10.1148/radiology.137.3.7003648

L. Ostergaard, A. Sorensen, K. Kwong, R. Weisskoff, C. Gyldensted et al., High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results, Magnetic Resonance in Medicine, vol.23, issue.5, pp.726-762, 1996.
DOI : 10.1002/mrm.1910360511

K. Miles, M. Hayball, and A. Dixon, Functional images of hepatic perfusion obtained with dynamic CT., Radiology, vol.188, issue.2, pp.405-416, 1993.
DOI : 10.1148/radiology.188.2.8327686

G. Brix, M. Bahner, U. Hoffmann, A. Horvath, and W. Schreiber, Regional Blood Flow, Capillary Permeability, and Compartmental Volumes: Measurement with Dynamic CT???Initial Experience, Radiology, vol.210, issue.1, pp.269-76, 1999.
DOI : 10.1148/radiology.210.1.r99ja46269

G. Brix, W. Semmler, R. Port, L. Schad, G. Layer et al., Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging, Journal of Computer Assisted Tomography, vol.15, issue.4, pp.621-629, 1991.
DOI : 10.1097/00004728-199107000-00018

G. Brix, F. Kiessling, and R. Lucht, Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series, Magnetic Resonance in Medicine, vol.4, issue.2, pp.420-429, 2004.
DOI : 10.1002/mrm.20161

H. Larsson, T. Fritz-hansen, E. Rostrup, L. Søndergaard, P. Ring et al., Myocardial perfusion modeling using MRI, Magnetic Resonance in Medicine, vol.16, issue.5, pp.716-742, 1996.
DOI : 10.1002/mrm.1910350513

P. Patel, S. Koppenhafer, and T. Scholz, Measurement of kinetic perfusion parameters of gadoteridol in intact myocardium: Effects of ischemia/reperfusion and coronary vasodilation, Magnetic Resonance Imaging, vol.13, issue.6, pp.799-806, 1995.
DOI : 10.1016/0730-725X(95)00032-C

C. Patlak, R. Blasberg, and J. Fenstermacher, Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data, Journal of Cerebral Blood Flow & Metabolism, vol.84, issue.1, pp.1-7, 1983.
DOI : 10.1111/j.1471-4159.1977.tb10649.x

K. Miles and B. Kelley, CT measurements of capillary permeability within nodal masses: a potential technique for assessing the activity of lymphoma., The British Journal of Radiology, vol.70, issue.829, pp.74-83, 1997.
DOI : 10.1259/bjr.70.829.9059299

D. Shames, R. Kuwatsuru, V. Vexler, A. Mühler, and R. Brasch, Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique, Magnetic Resonance in Medicine, vol.4, issue.5
DOI : 10.1002/mrm.1910290506

P. Tofts, Modeling tracer kinetics in dynamic Gd-DTPA MR imaging, Journal of Magnetic Resonance Imaging, vol.11, issue.1, pp.91-101, 1997.
DOI : 10.1002/jmri.1880070113

C. De-bazelaire, N. Siauve, and L. Fournier, Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma, European Radiology, vol.58, issue.Suppl 1, pp.2497-505, 2005.
DOI : 10.1007/s00330-005-2873-z

D. Balvay, F. Frouin, and G. Calmon, New criteria for assessing fit quality in dynamic contrast-enhancedT1-weighted MRI for perfusion and permeability imaging, Magnetic Resonance in Medicine, vol.47, issue.4, pp.868-77, 2005.
DOI : 10.1002/mrm.20650

M. Nakahira, N. Saito, H. Yamaguchi, K. Kuba, and M. Sugasawa, Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma, European Archives of Oto-Rhino-Laryngology, vol.241, issue.Suppl 1, pp.1219-1244, 2014.
DOI : 10.1007/s00405-013-2641-7

G. Larsen, C. Gyldenløve, M. Jensen, and D. , Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review, British Journal of Cancer, vol.140, issue.6, pp.1587-94, 2014.
DOI : 10.1038/bjc.2012.264

F. Lee, A. King, B. Ma, and D. Yeung, Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers, European Journal of Radiology, vol.81, issue.4, pp.784-792, 2012.
DOI : 10.1016/j.ejrad.2011.01.089

D. Gandhi, E. Hoeffner, R. Carlos, I. Case, and S. Mukherji, Computed Tomography Perfusion of Squamous Cell Carcinoma of the Upper Aerodigestive Tract, Journal of Computer Assisted Tomography, vol.27, issue.5, pp.687-93, 2003.
DOI : 10.1097/00004728-200309000-00005

R. Hermans, M. Meijerink, W. Van-den-bogaert, A. Rijnders, C. Weltens et al., Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.57, issue.5, pp.1351-1357, 2003.
DOI : 10.1016/S0360-3016(03)00764-8

A. Zima, R. Carlos, D. Gandhi, I. Case, T. Teknos et al., Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?, AJNR Am J Neuroradiol, vol.28, pp.328-362, 2007.

M. Varia, D. Calkins-adams, and L. Rinker, Pimonidazole: A Novel Hypoxia Marker for Complementary Study of Tumor Hypoxia and Cell Proliferation in Cervical Carcinoma, Gynecologic Oncology, vol.71, issue.2, pp.270-277, 1998.
DOI : 10.1006/gyno.1998.5163

S. Donaldson, G. Betts, and S. Bonington, Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.1176-83, 2011.
DOI : 10.1016/j.ijrobp.2010.09.039

J. Bernstein, J. Homer, and C. West, Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: Potential to guide treatment? A systematic review, Oral Oncology, vol.50, issue.10, 2014.
DOI : 10.1016/j.oraloncology.2014.07.011

S. Sourbron and D. Buckley, On the scope and interpretation of the Tofts models for DCE-MRI, Magnetic Resonance in Medicine, vol.181, issue.Suppl 1, pp.735-780, 2011.
DOI : 10.1002/mrm.22861

C. Cuenod, L. Fournier, D. Balvay, and J. Guinebretière, Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment, Abdominal Imaging, vol.74, issue.2, pp.188-93, 2006.
DOI : 10.1007/s00261-005-0386-5

URL : https://hal.archives-ouvertes.fr/inserm-00147472

N. Siauve, O. Clément, C. Cuénod, S. Benderbous, and G. Frija, Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: Pharmacokinetics and imaging implications, Magnetic Resonance Imaging, vol.14, issue.4
DOI : 10.1016/0730-725X(96)00020-3

O. Hauger, C. Delalande, and C. Deminière, Nephrotoxic Nephritis and Obstructive Nephropathy: Evaluation with MR Imaging Enhanced with Ultrasmall Superparamagnetic Iron Oxide???Preliminary Findings in a Rat Model, Radiology, vol.217, issue.3, pp.819-845, 2000.
DOI : 10.1148/radiology.217.3.r00dc04819

H. Anderson, P. Price, M. Blomley, M. Leach, and P. Workman, Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques, British Journal of Cancer, vol.85, issue.8, pp.1085-93, 2001.
DOI : 10.1054/bjoc.2001.2077

J. Ferlay, I. Soerjomataram, and M. Ervik, Cancer Incidence and Mortality Worldwide: IARC CancerBase No, 2013.

K. Annertz, H. Anderson, and A. Biörklund, Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults, International Journal of Cancer, vol.51, issue.2, pp.95-104, 2002.
DOI : 10.1002/ijc.10577

D. Conway, D. Stockton, K. S. Warnakulasuriya, G. Ogden, and L. Macpherson, Incidence of oral and oropharyngeal cancer in United Kingdom (1990???1999)???recent trends and regional variation, Oral Oncology, vol.42, issue.6, pp.586-92, 2006.
DOI : 10.1016/j.oraloncology.2005.10.018

S. Schantz and G. Yu, Head and Neck Cancer Incidence Trends in Young Americans, 1973-1997, With a Special Analysis for Tongue Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.128, issue.3, pp.268-74, 2002.
DOI : 10.1001/archotol.128.3.268

C. Shiboski, B. Schmidt, and R. Jordan, Tongue and tonsil carcinoma, Cancer, vol.37, issue.9, pp.1843-1852, 2005.
DOI : 10.1002/cncr.20998

A. Chaturvedi, E. Engels, W. Anderson, and M. Gillison, Incidence Trends for Human Papillomavirus???Related and ???Unrelated Oral Squamous Cell Carcinomas in the United States, Journal of Clinical Oncology, vol.26, issue.4, pp.612-621, 2008.
DOI : 10.1200/JCO.2007.14.1713

S. Golas, Trends in palatine tonsillar cancer incidence and mortality rates in the United States, Community Dentistry and Oral Epidemiology, vol.39, issue.2, pp.98-108, 2007.
DOI : 10.1093/jnci/94.20.1537

G. Corrao, V. Bagnardi, A. Zambon, L. Vecchia, and C. , A meta-analysis of alcohol consumption and the risk of 15 diseases, Preventive Medicine, vol.38, issue.5, pp.613-622, 2004.
DOI : 10.1016/j.ypmed.2003.11.027

V. Bagnardi, M. Rota, and E. Botteri, Light alcohol drinking and cancer: a meta-analysis, Annals of Oncology, vol.24, issue.2, pp.301-309, 2013.
DOI : 10.1093/annonc/mds337

H. Viswanathan and J. Wilson, Alcohol - the neglected risk factor in head and neck cancer, Clinical Otolaryngology and Allied Sciences, vol.88, issue.4, pp.295-300, 2004.
DOI : 10.1002/1097-0347(200007)22:4<317::AID-HED1>3.0.CO;2-0

A. , E. J. Raymond, and L. , Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France), Int J Cancer, vol.41, pp.483-91, 1988.

P. Boffetta and M. Hashibe, Alcohol and cancer, The Lancet Oncology, vol.7, issue.2, pp.149-56, 2006.
DOI : 10.1016/S1470-2045(06)70577-0

URL : https://hal.archives-ouvertes.fr/hal-01260905

M. Miller and P. , Young people and alcohol: an international insight, Alcohol Alcohol, vol.36, pp.513-518, 2001.

E. Sturgis and P. Cinciripini, Trends in head and neck cancer incidence in relation to smoking prevalence, Cancer, vol.9, issue.7, pp.1429-1464, 2007.
DOI : 10.1002/cncr.22963

A. Wyss, M. Hashibe, and S. Chuang, Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium, American Journal of Epidemiology, vol.178, issue.5, pp.679-90, 2013.
DOI : 10.1093/aje/kwt029

URL : https://hal.archives-ouvertes.fr/hal-01261751

Y. Arnson, Y. Shoenfeld, and H. Amital, Effects of tobacco smoke on immunity, inflammation and autoimmunity, Journal of Autoimmunity, vol.34, issue.3, pp.258-65, 2010.
DOI : 10.1016/j.jaut.2009.12.003

M. Rahman, J. Sakamoto, and T. Fukui, Bidi smoking and oral cancer: A meta-analysis, International Journal of Cancer, vol.29, issue.4, pp.600-604, 2003.
DOI : 10.1002/ijc.11265

A. Sapkota, V. Gajalakshmi, and D. Jetly, Smokeless tobacco and increased risk of hypopharyngeal and laryngeal cancers: A multicentric case???control study from India, International Journal of Cancer, vol.367, issue.8, pp.1793-1801, 2007.
DOI : 10.1002/ijc.22832

M. Chaturvedi, A. Kelsey, and K. , Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium, Cancer Epidemiol Biomarkers Prev, vol.23, pp.160-71, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01262498

M. Mclemore, M. Haigentz, and R. Smith, Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations, Head and Neck Pathology, vol.110, issue.Suppl 1, pp.97-105, 2010.
DOI : 10.1007/s12105-010-0171-9

H. Van-monsjou, V. Wreesmann, M. Van-den-brekel, and A. Balm, Head and neck squamous cell carcinoma in young patients, Oral Oncology, vol.49, issue.12, pp.1097-102, 2013.
DOI : 10.1016/j.oraloncology.2013.09.001

E. Leoncini, W. Ricciardi, and G. Cadoni, Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium, European Journal of Epidemiology, vol.40, issue.3, pp.35-48, 2014.
DOI : 10.1007/s10654-013-9863-2

URL : https://hal.archives-ouvertes.fr/hal-01261722

S. Paget-bailly, D. Cyr, M. Carton, F. Guida, I. Stucker et al., 0234???Head and neck cancer and occupational exposure to asbestos, mineral wools and silica: results from the ICARE study, Occupational and Environmental Medicine, vol.71, issue.Suppl 1, p.90, 2014.
DOI : 10.1136/oemed-2014-102362.280

R. Weinberg, Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis, Cancer Res, vol.49, pp.3713-3734, 1989.

D. Slaughter, H. Southwick, and W. Smejkal, ???Field cancerization??? in oral stratified squamous epithelium. Clinical implications of multicentric origin, Cancer, vol.20, issue.5, pp.963-971, 1953.
DOI : 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

J. Califano, P. Van-der-riet, and W. Westra, Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization, Otolaryngology-Head and Neck Surgery, vol.115, issue.2, pp.2488-92, 1996.
DOI : 10.1016/S0194-5998(96)80631-0

G. Bedi, W. Westra, E. Gabrielson, W. Koch, and D. Sidransky, Multiple head and neck tumors: evidence for a common clonal origin, Cancer Res, vol.56, pp.2484-2491, 1996.

A. Moustakas and C. Heldin, Signaling networks guiding epithelial?mesenchymal transitions during embryogenesis and cancer progression, Cancer Science, vol.4, issue.10, pp.1512-1532, 2007.
DOI : 10.1096/fj.04-2370com

S. Mani, W. Guo, and M. Liao, The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-719, 2008.
DOI : 10.1016/j.cell.2008.03.027

C. Chung, J. Parker, and K. Ely, Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-??B Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma, Cancer Research, vol.66, issue.16, pp.8210-8218, 2006.
DOI : 10.1158/0008-5472.CAN-06-1213

M. Worsham, K. Chen, and V. Meduri, Epigenetic Events of Disease Progression in Head and Neck Squamous Cell Carcinoma, Archives of Otolaryngology???Head & Neck Surgery, vol.132, issue.6, pp.668-77, 2006.
DOI : 10.1001/archotol.132.6.668

J. Thariat, L. Milas, and K. Ang, Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.4, pp.974-84, 2007.
DOI : 10.1016/j.ijrobp.2007.06.076

F. Dammann, M. Horger, and M. Mueller-berg, FDG PET, American Journal of Roentgenology, vol.184, issue.4, pp.1326-1357, 2005.
DOI : 10.2214/ajr.184.4.01841326

J. Daisne, T. Duprez, and B. Weynand, Tumor Volume in Pharyngolaryngeal Squamous Cell Carcinoma: Comparison at CT, MR Imaging, and FDG PET and Validation with Surgical Specimen, Radiology, vol.233, issue.1, pp.93-100, 2004.
DOI : 10.1148/radiol.2331030660

V. Paidpally, A. Chirindel, S. Lam, N. Agrawal, H. Quon et al., FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma, Imaging in Medicine, vol.4, issue.6, pp.633-680, 2012.
DOI : 10.2217/iim.12.60

J. Thariat, F. Jegoux, and Y. Pointreau, Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC], Bull Cancer, vol.100, pp.983-97, 2013.

J. Greenberg, E. Naggar, A. Mo, V. Roberts, D. Myers et al., Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma, Cancer, vol.9, issue.3, pp.508-523, 2003.
DOI : 10.1002/cncr.11526

F. Dubrulle, N. Martin-duverneuil, G. Moulin, and A. Varoquaux, Imagerie en ORL. Issy-les- Moulineaux, 2010.

C. Badoual, C. Righini, and B. Barry, Pre-therapeutic histological and cytological assessment in head and neck squamous cell carcinomas. French Society of Otorhinolaryngology Guidelines ??? 2012, European Annals of Otorhinolaryngology, Head and Neck Diseases, vol.129, issue.6, pp.319-345, 2012.
DOI : 10.1016/j.anorl.2012.09.001

G. Psychogios, K. Mantsopoulos, and A. Agaimy, Outcome and Prognostic Factors in T4a Oropharyngeal Carcinoma, Including the Role of HPV Infection, BioMed Research International, vol.62, issue.4, p.390825, 2014.
DOI : 10.1007/s00405-010-1344-6

M. Bonifazi, M. Malvezzi, and P. Bertuccio, Age???period???cohort analysis of oral cancer mortality in Europe: The end of an epidemic?, Oral Oncology, vol.47, issue.5, pp.400-407, 2011.
DOI : 10.1016/j.oraloncology.2010.06.010

J. Pignon, A. Le-maître, E. Maillard, J. Bourhis, and M. Group, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients, Radiotherapy and Oncology, vol.92, issue.1, pp.4-14, 2009.
DOI : 10.1016/j.radonc.2009.04.014

J. Pignon, J. Bourhis, C. Domenge, and L. Designé, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer, Cancer/Radioth??rapie, vol.5, issue.2, pp.949-55, 2000.
DOI : 10.1016/S1278-3218(00)00073-1

G. Perl, I. Ben-aharon, A. Popovtzer, S. Stemmer, and L. Vidal, Addition of Taxane to Induction Therapy in Head and Neck Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Chemotherapy, vol.59, issue.6, pp.435-475, 2013.
DOI : 10.1159/000360690

A. Cosmidis, J. Rame, and O. Dassonville, T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study, Eur Arch Otorhinolaryngol, vol.261, pp.276-81, 2004.

S. Marur, G. Dsouza, W. Westra, and A. Forastiere, HPV-associated head and neck cancer: a virus-related cancer epidemic, The Lancet Oncology, vol.11, issue.8, pp.781-790, 2010.
DOI : 10.1016/S1470-2045(10)70017-6

J. Payne, On the contagiousness of common warts, Br J Dermatol, vol.1891, pp.185-193

G. Variot, Un cas ddinoculation experimentale des verrues de lenfant { lhomme, J Clin Ther Inf, pp.529-563, 1894.

J. Jadassohn, Sind die Verrucae vulgares ubertragbar?, Verhandl Deutsch Dermat Gesellsch, p.497, 1896.

G. Ciuffo, Innesto positivo con filtrato di verruca volgare. G Ital Mal Vener, pp.12-19

P. Rous and J. Beard, A VIRUS-INDUCED MAMMALIAN GROWTH WITH THE CHARACTERS OF A TUMOR (THE SHOPE RABBIT PAPILLOMA): III. FURTHER CHARACTERS OF THE GROWTH: GENERAL DISCUSSION, Journal of Experimental Medicine, vol.60, issue.6, pp.741-66, 1934.
DOI : 10.1084/jem.60.6.741

M. Strauss and E. Shaw, "Crystalline" Virus-Like Particles from Skin Papillomas Characterized by Intranuclear Inclusion Bodies., Experimental Biology and Medicine, vol.72, issue.1, pp.46-50, 1949.
DOI : 10.3181/00379727-72-17328

J. Melnick, Papova Virus Group, Science, vol.135, issue.3509, pp.1128-1158, 1962.
DOI : 10.1126/science.135.3509.1128

H. Hausen, Condylomata acuminata and human genital cancer, Cancer Res, vol.36, p.794, 1976.

H. Hausen, Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas, Curr Top Microbiol Immunol, vol.78, pp.1-30, 1977.
DOI : 10.1007/978-3-642-66800-5_1

S. Chan, H. Bernard, M. Ratterree, T. Birkebak, A. Faras et al., Genomic diversity and evolution of papillomaviruses in rhesus monkeys, J Virol, vol.71, pp.4938-4981, 1997.

L. Ho, S. Chan, and R. Burk, The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations, J Virol, vol.67, pp.6413-6436, 1993.

C. Ong, S. Chan, and M. Campo, Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups, J Virol, vol.67, pp.6424-6455, 1993.

S. Chan, L. Ho, and C. Ong, Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind, J Virol, vol.66, pp.2057-66, 1992.

K. Syrjänen, S. Syrjänen, M. Lamberg, S. Pyrhönen, and J. Nuutinen, Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis, International Journal of Oral Surgery, vol.12, issue.6
DOI : 10.1016/S0300-9785(83)80033-7

T. Löning, H. Ikenberg, J. Becker, L. Gissmann, I. Hoepfer et al., Analysis of Oral Papillomas, Leukoplakias, and Invasive Carcinomas for Human Papillomavirus Type Related DNA, Journal of Investigative Dermatology, vol.84, issue.5, pp.417-437, 1985.
DOI : 10.1111/1523-1747.ep12265517

D. Villiers, E. Fauquet, C. Broker, T. Bernard, and H. Zur-hausen, Classification of papillomaviruses, Virology, vol.324, issue.1, pp.17-27, 2004.
DOI : 10.1016/j.virol.2004.03.033

M. Carrillo-tripp, C. Shepherd, and I. Borelli, VIPERdb2: an enhanced and web API enabled relational database for structural virology, Nucleic Acids Research, vol.37, issue.Database, pp.436-478, 2009.
DOI : 10.1093/nar/gkn840

V. Bouvard, G. Matlashewski, Z. Gu, A. Storey, and L. Banks, The Human Papillomavirus Type 16 E5 Gene Cooperates with the E7 Gene to Stimulate Proliferation of Primary Cells and Increases Viral Gene Expression, Virology, vol.203, issue.1, pp.73-80, 1994.
DOI : 10.1006/viro.1994.1456

V. Knebel-doeberitz and M. , New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections, European Journal of Cancer, vol.38, issue.17, pp.2229-2271, 2002.
DOI : 10.1016/S0959-8049(02)00462-8

F. Fehrmann and L. Laimins, Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation, Oncogene, vol.22, issue.33, pp.5201-5208, 2003.
DOI : 10.1038/sj.onc.1206554

I. Frazer, Prevention of cervical cancer through papillomavirus vaccination, Nature Reviews Immunology, vol.4, issue.1, pp.46-54, 2004.
DOI : 10.1038/nri1260

A. Singhi and W. Westra, Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience, Cancer, vol.24, pp.2166-73, 2010.
DOI : 10.1002/cncr.25033

D. Sanjosé, S. Diaz, M. Castellsagué, and X. , Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, The Lancet Infectious Diseases, vol.7, issue.7, pp.453-462, 2007.
DOI : 10.1016/S1473-3099(07)70158-5

A. Kreimer, R. Bhatia, A. Messeguer, P. González, R. Herrero et al., Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature, Sexually Transmitted Diseases, vol.37, pp.386-91, 2010.
DOI : 10.1097/OLQ.0b013e3181c94a3b

A. Sanders, G. Slade, and L. Patton, National prevalence of oral HPV infection and related risk factors in the U.S. adult population, Oral Diseases, vol.23, issue.Suppl 1, pp.430-471, 2012.
DOI : 10.1111/j.1601-0825.2011.01892.x

Z. Edelstein, S. Schwartz, and S. Hawes, Rates and Determinants of Oral Human Papillomavirus Infection in Young Men, Sexually Transmitted Diseases, vol.39, issue.11, pp.860-867, 2012.
DOI : 10.1097/OLQ.0b013e318269d098

M. Cañadas, F. Bosch, and M. Junquera, Concordance of Prevalence of Human Papillomavirus DNA in Anogenital and Oral Infections in a High-Risk Population, Journal of Clinical Microbiology, vol.42, issue.3, pp.1330-1332, 2004.
DOI : 10.1128/JCM.42.3.1330-1332.2004

R. Herrero, X. Castellsagué, and M. Pawlita, Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study, CancerSpectrum Knowledge Environment, vol.95, issue.23, pp.1772-83, 2003.
DOI : 10.1093/jnci/djg107

L. Markowitz, M. Sternberg, E. Dunne, G. Mcquillan, and E. Unger, Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003???2004, The Journal of Infectious Diseases, vol.200, issue.7, pp.1059-67, 2003.
DOI : 10.1086/604729

H. Mehanna, T. Beech, and T. Nicholson, Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region, Head & Neck, vol.45, issue.5, pp.747-55, 2013.
DOI : 10.1002/hed.22015

L. Hammarstedt, D. Lindquist, and H. Dahlstrand, Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer, International Journal of Cancer, vol.104, issue.11, pp.2620-2623, 2006.
DOI : 10.1002/ijc.22177

A. Kreimer, G. Clifford, P. Boyle, and S. Franceschi, Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.2, pp.467-75, 2005.
DOI : 10.1158/1055-9965.EPI-04-0551

P. Castle, M. Schiffman, and R. Herrero, A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica, The Journal of Infectious Diseases, vol.191, issue.11, pp.1808-1824, 2005.
DOI : 10.1086/428779

H. Hausen, Papillomaviruses and cancer: from basic studies to clinical application, Nature Reviews Cancer, vol.2, issue.5, pp.342-50, 2002.
DOI : 10.1038/nrc798

A. Kreimer, P. Campbell, C. Lin, and H. , Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study, The Lancet, vol.382, issue.9895, pp.877-87, 2013.
DOI : 10.1016/S0140-6736(13)60809-0

R. Pickard, X. W. Broutian, T. He, X. Gillison, and M. , The Prevalence and Incidence of Oral Human Papillomavirus Infection Among Young Men and Women, Aged 18???30 Years, Sexually Transmitted Diseases, vol.39, issue.7, pp.559-66, 2012.
DOI : 10.1097/OLQ.0b013e31824f1c65

M. Gillison, T. Broutian, and R. Pickard, Prevalence of Oral HPV Infection in the United States, 2009-2010, JAMA, vol.307, issue.7, pp.693-703, 2009.
DOI : 10.1001/jama.2012.101

E. Shatalova, A. Klein-szanto, K. Devarajan, E. Cukierman, and M. Clapper, Estrogen and Cytochrome P450 1B1 Contribute to Both Early- and Late-Stage Head and Neck Carcinogenesis, Cancer Prevention Research, vol.4, issue.1, pp.107-122, 2011.
DOI : 10.1158/1940-6207.CAPR-10-0133

M. Safaeian, C. Porras, and M. Schiffman, Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections, JNCI Journal of the National Cancer Institute, vol.102, issue.21, pp.1653-62, 2010.
DOI : 10.1093/jnci/djq384

A. Kreimer, A. Villa, and A. Nyitray, The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men, Cancer Epidemiology Biomarkers & Prevention, vol.20, issue.1, pp.172-82, 2011.
DOI : 10.1158/1055-9965.EPI-10-0682

G. Ddsouza, Y. Agrawal, J. Halpern, S. Bodison, and M. Gillison, Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection, The Journal of Infectious Diseases, vol.199, issue.9, pp.1263-1272, 2009.
DOI : 10.1086/597755

P. Sinha, H. Logan, and W. Mendenhall, Human papillomavirus, smoking, and head and neck cancer, American Journal of Otolaryngology, vol.33, issue.1, pp.130-136, 2012.
DOI : 10.1016/j.amjoto.2011.02.001

P. Boscolo-rizzo, D. Mistro, A. Bussu, and F. , New insights into human papillomavirus-associated head and neck squamous cell carcinoma, Acta Otorhinolaryngol Ital, vol.33, pp.77-87, 2013.

A. Chaturvedi, W. Anderson, and J. Lortet-tieulent, Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers, Journal of Clinical Oncology, vol.31, issue.36, pp.4550-4559, 2013.
DOI : 10.1200/JCO.2013.50.3870

URL : https://hal.archives-ouvertes.fr/hal-01261786

M. Gillison, X. Castellsagué, and A. Chaturvedi, Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix, International Journal of Cancer, vol.13, issue.Suppl 5, pp.497-507, 2014.
DOI : 10.1002/ijc.28201

M. 181-rietbergen, B. Braakhuis, and N. Moukhtari, No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors, Journal of Oral Pathology & Medicine, vol.97, issue.Suppl 1, pp.137-179, 2014.
DOI : 10.1111/jop.12123

K. Jain, A. Sikora, S. Baxi, and L. Morris, Synchronous cancers in patients with head and neck cancer, Cancer, vol.135, issue.suppl 1, pp.1832-1839, 2013.
DOI : 10.1002/cncr.27988

D. Pyeon, M. Newton, and P. Lambert, Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus-Positive and Human Papillomavirus-Negative Head/Neck and Cervical Cancers, Cancer Research, vol.67, issue.10, pp.4605-4624, 2007.
DOI : 10.1158/0008-5472.CAN-06-3619

S. Pal, K. Datta, and D. Mukhopadhyay, Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma, Cancer Res, vol.61, pp.6952-6959, 2001.

M. Ghahremani, S. Goossens, and D. Nittner, p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway, Cell Death and Differentiation, vol.61, issue.7, pp.888-97, 2013.
DOI : 10.1093/nar/gkr355

R. Ravi, B. Mookerjee, and Z. Bhujwalla, Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha, Genes Dev, vol.14, pp.34-44, 2000.

T. Wiest, E. Schwarz, C. Enders, C. Flechtenmacher, and F. Bosch, Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control, Oncogene, vol.21, issue.10
DOI : 10.1038/sj.onc.1205214

M. Dürst, R. Dzarlieva-petrusevska, P. Boukamp, N. Fusenig, and L. Gissmann, Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA, Oncogene, vol.1, pp.251-257, 1987.

C. Woodworth, J. Doniger, and J. Dipaolo, Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma, J Virol, vol.63, pp.159-64, 1989.

W. Spanos, J. Geiger, and M. Anderson, Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells, Head & Neck, vol.80, issue.2, pp.139-186, 2008.
DOI : 10.1002/hed.20673

M. Einstein, J. Schiller, and R. Viscidi, Clinician's guide to human papillomavirus immunology: knowns and unknowns, The Lancet Infectious Diseases, vol.9, issue.6, pp.347-56, 2009.
DOI : 10.1016/S1473-3099(09)70108-2

J. Doorbar, The papillomavirus life cycle, Journal of Clinical Virology, vol.32, issue.1, pp.7-15, 2005.
DOI : 10.1016/j.jcv.2004.12.006

S. Fausch, D. Silva, D. Rudolf, M. Kast, and W. , Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses, The Journal of Immunology, vol.169, issue.6, pp.3242-3251, 2002.
DOI : 10.4049/jimmunol.169.6.3242

D. Jong, A. Van-poelgeest, M. Van-der-hulst, and J. , Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6, Cancer Research, vol.64, issue.15, pp.5449-55, 2004.
DOI : 10.1158/0008-5472.CAN-04-0831

R. Viscidi, B. Snyder, and S. Cu-uvin, Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women, Cancer Epidemiol Biomarkers Prev, vol.14, pp.283-291, 2005.

R. Viscidi, M. Schiffman, and A. Hildesheim, Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.2
DOI : 10.1158/1055-9965.EPI-03-0166

I. Frazer, Correlating immunity with protection for HPV infection, International Journal of Infectious Diseases, vol.11, issue.2, pp.10-16, 2007.
DOI : 10.1016/S1201-9712(07)60016-2

L. Marklund and L. Hammarstedt, Impact of HPV in Oropharyngeal Cancer, Journal of Oncology, vol.96, issue.13, p.509036, 2011.
DOI : 10.1016/j.ejca.2010.04.016

M. Gillison, W. Koch, and R. Capone, Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers, Journal of the National Cancer Institute, vol.92, issue.9, pp.709-729, 2000.
DOI : 10.1093/jnci/92.9.709

A. Näsman, P. Attner, and L. Hammarstedt, Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?, International Journal of Cancer, vol.9, issue.2, pp.362-368, 2009.
DOI : 10.1002/ijc.24339

J. Mork, A. Lie, and E. Glattre, Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck, New England Journal of Medicine, vol.344, issue.15, pp.1125-1156, 2001.
DOI : 10.1056/NEJM200104123441503

J. Klussmann, S. Weissenborn, and U. Wieland, Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas, Cancer, vol.356, issue.11, pp.2875-84, 2001.
DOI : 10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7

J. Combes and S. Franceschi, Role of human papillomavirus in non-oropharyngeal head and neck cancers, Oral Oncology, vol.50, issue.5, pp.370-379, 2014.
DOI : 10.1016/j.oraloncology.2013.11.004

T. Isayeva, Y. Li, D. Maswahu, and M. Brandwein-gensler, Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review, Head and Neck Pathology, vol.5, issue.Suppl 1, pp.104-124, 2012.
DOI : 10.1007/s12105-012-0368-1

S. Wilczynski, B. Lin, Y. Xie, and I. Paz, Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma, Am J Pathol, vol.152, pp.145-56, 1998.

S. Begum and W. Westra, Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status, The American Journal of Surgical Pathology, vol.32, issue.7, pp.1044-50, 2008.
DOI : 10.1097/PAS.0b013e31816380ec

D. Goldenberg, S. Begum, and W. Westra, Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon, Head & Neck, vol.106, issue.7, pp.898-903, 2008.
DOI : 10.1002/hed.20796

J. Rainsbury, W. Ahmed, H. Williams, S. Roberts, V. Paleri et al., Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis, Head & Neck, vol.20, issue.Suppl 1, pp.1048-55, 2013.
DOI : 10.1002/hed.22950

C. Liang, C. Marsit, and M. Mcclean, Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma, Cancer Research, vol.72, issue.19, pp.5004-5017, 2012.
DOI : 10.1158/0008-5472.CAN-11-3277

C. Fakhry, W. Westra, and S. Li, Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial, JNCI Journal of the National Cancer Institute, vol.100, issue.4, pp.261-270, 2008.
DOI : 10.1093/jnci/djn011

P. Lassen, J. Eriksen, S. Hamilton-dutoit, T. Tramm, J. Alsner et al., Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck, Journal of Clinical Oncology, vol.27, issue.12, pp.1992-2000, 2009.
DOI : 10.1200/JCO.2008.20.2853

P. Weinberger, Z. Yu, and B. Haffty, Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer, Clinical Cancer Research, vol.10, issue.17, pp.5684-91, 2004.
DOI : 10.1158/1078-0432.CCR-04-0448

W. Shi, H. Kato, and B. Perez-ordonez, Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma, Journal of Clinical Oncology, vol.27, issue.36, pp.6213-6234, 2009.
DOI : 10.1200/JCO.2009.23.1670

S. Smeets, A. Hesselink, and E. Speel, A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen, International Journal of Cancer, vol.24, issue.11, pp.2465-72, 2007.
DOI : 10.1002/ijc.22980

A. El-naggar and W. Westra, p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency, Head & Neck, vol.67, issue.4, pp.459-61, 2012.
DOI : 10.1002/hed.21974

K. Kuo, C. Hsiao, C. Lin, L. Kuo, S. Huang et al., The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma???molecular basis and predicting favorable outcome, Modern Pathology, vol.33, issue.4
DOI : 10.1073/pnas.96.22.12754

A. Argiris, M. Karamouzis, D. Raben, and R. Ferris, Head and neck cancer, The Lancet, vol.371, issue.9625, pp.1695-709, 2008.
DOI : 10.1016/S0140-6736(08)60728-X

M. Oororke, M. Ellison, L. Murray, M. Moran, J. James et al., Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis, Oral Oncology, vol.48, issue.12, pp.1191-201, 2012.
DOI : 10.1016/j.oraloncology.2012.06.019

M. Hoffmann, A. Ihloff, and T. Görögh, (INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer, Int J Cancer, vol.127, pp.16-1595, 2010.

C. Fischer, I. Zlobec, and E. Green, Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?, International Journal of Cancer, vol.70, pp.1256-62, 2010.
DOI : 10.1002/ijc.24842

R. Chernock, S. El-mofty, W. Thorstad, C. Parvin, and J. Lewis, HPV-Related Nonkeratinizing Squamous Cell Carcinoma of the Oropharynx: Utility of Microscopic Features in Predicting Patient Outcome, Head and Neck Pathology, vol.92, issue.2, pp.186-94, 2009.
DOI : 10.1007/s12105-009-0126-1

A. Mendelsohn, C. Lai, and I. Shintaku, Histopathologic findings of HPV and p16 positive HNSCC, The Laryngoscope, vol.119, issue.9, pp.1788-94, 2010.
DOI : 10.1002/lary.21044

J. Lewis, p16 Immunohistochemistry As a Standalone Test for Risk Stratification in Oropharyngeal Squamous Cell Carcinoma, Head and Neck Pathology, vol.9, issue.6, pp.75-82, 2012.
DOI : 10.1007/s12105-012-0369-0

J. Thomas and T. Primeaux, Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus???associated head and neck squamous cell carcinoma?, Annals of Diagnostic Pathology, vol.16, issue.2, pp.91-100, 2012.
DOI : 10.1016/j.anndiagpath.2011.09.002

R. Friedrich, C. Sperber, T. Jäkel, K. Röser, and T. Löning, Basaloid lesions of oral squamous epithelial cells and their association with HPV infection and P16 expression, Anticancer Res, vol.30, pp.1605-1617, 2010.

T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima, Expression Status of p16 Protein Is Associated with Human Papillomavirus Oncogenic Potential in Cervical and Genital Lesions, The American Journal of Pathology, vol.153, issue.6, pp.1741-1749, 1998.
DOI : 10.1016/S0002-9440(10)65689-1

J. Klussmann, E. Gültekin, and S. Weissenborn, Expression of p16 Protein Identifies a Distinct Entity of Tonsillar Carcinomas Associated with Human Papillomavirus, The American Journal of Pathology, vol.162, issue.3, pp.747-53, 2003.
DOI : 10.1016/S0002-9440(10)63871-0

S. Mukherji and J. Castelijns, CT Perfusion of Head and Neck Cancer: Why We Should Care versus Why Should We Care!, American Journal of Neuroradiology, vol.31, issue.3, pp.391-394, 2010.
DOI : 10.3174/ajnr.A1964

J. Keating, A. Cviko, and S. Riethdorf, Ki-67, Cyclin E, and p16 INK4 Are Complimentary Surrogate Biomarkers for Human Papilloma Virus-Related Cervical Neoplasia, The American Journal of Surgical Pathology, vol.25, issue.7, pp.884-91, 2001.
DOI : 10.1097/00000478-200107000-00006

N. Hoefling, J. Mchugh, and E. Light, Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma, American Journal of Neuroradiology, vol.34, issue.5, pp.1062-1068, 2013.
DOI : 10.3174/ajnr.A3349

F. Dayyani, C. Etzel, M. Liu, C. Ho, S. Lippman et al., Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC), Head & Neck Oncology, vol.2, issue.1, p.15, 2010.
DOI : 10.1186/1758-3284-2-15

L. Tamás, G. Szentkúti, and M. Eros, Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization, Pathology & Oncology Research, vol.245, issue.25, pp.721-728, 2011.
DOI : 10.1007/s12253-011-9376-9

C. Bazelaire, R. Calmon, and I. Thomassin, Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study, BMC Cancer, vol.257, issue.1, p.361, 2011.
DOI : 10.1148/radiol.10092021

URL : https://hal.archives-ouvertes.fr/inserm-00623267

O. Craciunescu, D. Yoo, and C. E. , Dynamic Contrast-Enhanced MRI in Head-and-Neck Cancer: The Impact of Region of Interest Selection on the Intra- and Interpatient Variability of Pharmacokinetic Parameters, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3, pp.345-50, 2012.
DOI : 10.1016/j.ijrobp.2011.05.059